Abstract
The Etest glycopeptide resistance detection identified two potential heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) isolates from a screen of 288 methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients at a Connecticut Veterans Hospital. However, the two isolates did not meet the criteria for hVISA by the population analysis profile-area under the curve analysis, arguing against routine screening for hVISA in this low prevalence population.
MeSH terms
-
Aged
-
Anti-Bacterial Agents / administration & dosage
-
Area Under Curve
-
Bacterial Typing Techniques
-
Connecticut / epidemiology
-
False Positive Reactions
-
Humans
-
Male
-
Methicillin-Resistant Staphylococcus aureus / drug effects
-
Methicillin-Resistant Staphylococcus aureus / genetics*
-
Methicillin-Resistant Staphylococcus aureus / isolation & purification
-
Microbial Sensitivity Tests
-
Prevalence
-
Staphylococcal Infections / drug therapy*
-
Staphylococcal Infections / epidemiology
-
Staphylococcal Infections / microbiology
-
Vancomycin / administration & dosage*
-
Vancomycin Resistance*
-
Veterans
Substances
-
Anti-Bacterial Agents
-
Vancomycin